Macro

Q&A: BARDA wants to back tech that can combat multiple infections, says director

Following the rapid development and commercialisation of Covid-19 vaccines and therapeutics, multiple pharmaceutical companies such as AstraZeneca, Moderna, and Pfizer…

Merck reports drop in net income for fiscal 2023

Merck KGaA (Merck) has reported a decline in financial performance for the fiscal year 2023, with net income attributable to…

Moderna reports net loss of $4.7bn for full year 2023

Moderna has reported a net loss of $4.7bn for the full year 2023 as against a net income of $8.4bn…

Everest ends Covid-19 mRNA vaccine deal with Providence

China-based Everest Medicine has terminated its licensing and partnership agreement with Canada-based Providence Therapeutics.  Everest will pay $4m as part…

Psychedelic treatments for mental health: Is there substance behind the hype?

Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic…

Q4 2023 update: environmental sustainability related M&A activity in the pharmaceutical industry

Analysis of the key themes driving M&A activity reveals that environmental sustainability accounted for 6 pharmaceutical deals announced in Q4…

MHRA agrees licence change for Pfizer-BioNTech’s Comirnaty vaccine

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for a variation in licence for Pfizer-BioNTech’s 30…

AstraZeneca posts 81% rise in FY 2023 profit after tax

AstraZeneca has reported a significant 81% rise in profit after tax, reaching $5.96bn for the fiscal year (FY) 2023 from…

What is the UK’s Covid-19 drug armoury like amid rising infection levels?

Covid-19 cases in the UK have been picking up since November, with a 39% increase in positive tests in the…

HHS reiterates plans to allow Paxlovid access regardless of insurance  

In a meeting with healthcare providers, leaders from the US Department of Health and Human Services (HHS) went over ways…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close